Skip to main content
Equibles

Brant C. Binder

Board Member

Ernexa Therapeutics Inc. (ERNA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ERNA alerts

About Brant C. Binder

Brant C. Binder is recorded as Board Member at Ernexa Therapeutics Inc. (ERNA) since July 6, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed August 10, 2023 that Brant C. Binder resigned as Board, effective August 8, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed July 11, 2023 that Brant C. Binder was appointed director, effective July 6, 2023. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.

“On August 8, 2023, Mr. Brant C. Binder and Dr. Richard W. Wagner resigned from the Board, including from the audit and compensation committees thereof, of which they were two of three members, as well as from the Transaction Committee referenced in the Angel Letter.”
Ernexa Therapeutics Inc. Form 8-K, filed August 10, 2023 · Read the filing
“On July 6, 2023, the Board appointed Mr. Brant C. Binder and Dr. Richard W. Wagner as directors, with effect immediately following the effectiveness of the resignations of Messrs. Singer and Cherington, to fill the vacancies on the Board created thereby.”
Ernexa Therapeutics Inc. Form 8-K, filed July 11, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Ernexa Therapeutics Inc.

Recent activity